Despite decades of R&D effort, almost all biopharmaceuticals remain well beyond the reach of oral formulation technology. Today, these medicines are usually administered in a healthcare setting rather ...

Last year, the biotechnology industry celebrated the twentieth anniversary of the approval of the first true product of modern biotechnology—recombinant insulin (Humulin; Genentech, S. San Francisco, ...

Pfizer announced it will invest $465 million to build a new Modular Aseptic Processing Facility in Kalamazoo County, MI. The 400,000-square-foot facility, which will produce critical life-saving ...

With the increasing amount of available data, AI and machine learning have emerged as crucial tools for biopharmaceutical companies looking to remain competitive in the market. These tools are helping ...

Biopharmaceuticals, also known as biologics, are a class of medicines produced using living systems such as microorganisms, plant or animal cells, or recombinant DNA technology. Unlike traditional ...

Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals. The current biopharmaceutical industry is estimated at more than $400 billion/year revenue and continues to ...

The accurate characterization of proteins and other compounds is a major determinant of success in biopharmaceutical development. Molecular insights obtained by analytical technologies guide the ...

An understanding of human complexity requires knowing not only the total number of genes but the proteome that is generated through differential splicing of nuclear RNA, protein PTMs and the release ...

The Biopharmaceuticals Market value was US$ $$ billion in 2022. The Biopharmaceuticals Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% ...